California DEA Registration Deadline June 22: What Licensees Must Know

The clock is running. On June 22, 2026, the 60-day DEA registration window for state-licensed medical marijuana operators closes. For the approximately 1,600 California licensees eligible to pursue registration, the next three weeks represent the most consequential compliance deadline in the history of the state's cannabis program.

The stakes are high. Registration offers priority federal review, a safe harbor to continue operations during the transition period, and a target six-month processing turnaround. Missing the window does not make registration impossible — but it eliminates the priority benefits that make the difference between a smooth transition and months of regulatory uncertainty.

Here is what happened, who needs to act, and how the pieces fit together.

How we got here: the April 23 reclassification

On April 23, 2026, the Department of Justice officially moved state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act, effective April 28. This action was the culmination of a process that began with the Department of Health and Human Services' recommendation to reschedule cannabis and wound through months of interagency review before reaching the rulemaking stage.

The reclassification was narrowly scoped. It applies to two categories of cannabis: FDA-approved marijuana-derived products and marijuana cultivated, processed, distributed, and dispensed under state-licensed medical programs. Cannabis that falls outside these categories — including all adult-use marijuana sold in recreational markets — remains Schedule I pending the broader DEA rescheduling hearing set to begin June 29.

The narrow scope is important for California operators because the state's cannabis licensing system encompasses both medical and adult-use authorizations. Only operators with state medical licenses — or those who obtain them — are eligible for DEA registration under the current reclassification. Adult-use-only licensees are not covered.

Who must register

The DEA registration requirement applies to every entity in the state-licensed medical marijuana supply chain. This includes:

Cultivators with state medical cannabis cultivation licenses. These operations grow the cannabis that enters the medical supply chain and must register as DEA-authorized manufacturers of a Schedule III controlled substance.

Processors and manufacturers who transform raw cannabis into medical products — edibles, concentrates, tinctures, topicals, and other formulations. These operations must register under DEA categories that correspond to their manufacturing activities.

Distributors who transport cannabis products between licensees. The distribution function in cannabis operates similarly to pharmaceutical distribution, and DEA registration aligns these operations with the regulatory framework that governs other Schedule III substances.

Testing laboratories that analyze cannabis products for potency, contaminants, and compliance. Labs that test medical cannabis must register with the DEA to handle Schedule III substances in the course of their analytical work.

Dispensaries with state medical licenses that sell cannabis products directly to patients. Retail dispensaries are the final link in the supply chain and must register to legally dispense a Schedule III controlled substance.

The breadth of the registration requirement means that virtually every California cannabis business that touches the medical market needs to engage with the DEA registration process.

The 60-day window and its benefits

The DEA established a 60-day registration window beginning April 23 — the date of the reclassification announcement — and closing June 22. Operators who submit their registration applications within this window receive several important benefits.

Priority review. Applications submitted during the 60-day window are processed on a priority basis, ahead of applications submitted after the window closes. Given the volume of registrations the DEA is processing nationally — California alone has roughly 1,600 eligible licensees, and other medical marijuana states are generating their own registration volumes — priority positioning could mean the difference between a timely registration and months of waiting.

Safe harbor. Operators who submit applications within the window receive a safe harbor provision that allows them to continue their medical cannabis operations while their registration is pending. Without this safe harbor, operators would face a legal gray area: their state licenses authorize their activities under state law, but without DEA registration, their handling of a Schedule III substance is technically unauthorized under federal law. The safe harbor resolves this contradiction for the duration of the registration process.

Six-month target turnaround. The DEA has set a target of processing priority applications within six months. This timeline is not guaranteed — it is a stated goal, not a regulatory requirement — but it provides operators with a reasonable expectation for when their registration will be finalized.

Operators who miss the June 22 deadline can still apply for DEA registration. However, their applications will be processed in standard order rather than on a priority basis, and they will not receive the safe harbor protection that covers the period between application submission and registration approval.

California DCC emergency regulations

The California Department of Cannabis Control responded to the federal reclassification by issuing emergency regulations designed to enable licensees to navigate the transition.

The emergency regulations address several practical challenges that the reclassification creates for California's dual-license market structure.

Dual medical and adult-use operations on the same premises. California's cannabis market includes many businesses that hold both medical and adult-use licenses and operate both programs from the same physical location. The DCC's emergency regulations provide a framework for these dual-license operations to pursue DEA registration for their medical activities while continuing their adult-use operations under existing state authorization.

This is more complex than it sounds. DEA registration for medical cannabis activities imposes specific record-keeping, security, and inventory management requirements that must be maintained separately from adult-use operations, even when both occur in the same facility. The emergency regulations provide guidance on how to maintain this separation without requiring operators to physically split their operations into separate locations.

Tax implications. The reclassification of medical marijuana to Schedule III has immediate tax consequences. Schedule III substances are not subject to Section 280E of the Internal Revenue Code, which prohibits businesses trafficking in Schedule I or Schedule II substances from deducting ordinary business expenses. For medical cannabis operations, this means standard federal tax deductions become available — a potentially transformative financial change.

The DCC's emergency regulations include provisions related to tax treatment of medical versus adult-use operations, providing guidance on how operators should structure their accounting to capture the 280E relief available for their medical activities while maintaining compliance for their adult-use operations, which remain subject to 280E until and unless broader rescheduling occurs.

The broader Schedule III landscape

California's DEA registration process is unfolding against a backdrop of rapid federal regulatory development.

The DEA has confirmed that new registration forms are being developed specifically for medical cannabis operations. The existing DEA registration infrastructure was built for pharmaceutical manufacturers, pharmacies, hospitals, and research institutions — entities that look very different from cannabis cultivators and dispensaries. The new forms are intended to accommodate the unique characteristics of state-licensed medical marijuana operations.

Nationally, every state with a licensed medical marijuana program is navigating a similar transition. The DEA registration requirement applies uniformly, but each state's regulatory structure creates unique implementation challenges. California's dual-license market, its size (the largest cannabis market in the country by revenue), and the diversity of its licensee base make its transition particularly complex.

Meanwhile, cannabis that falls outside the medical reclassification — all adult-use marijuana and any cannabis not part of a state-licensed medical program — remains Schedule I. The DEA's broader rescheduling hearing, set to begin June 29 (just one week after California's registration window closes), will consider whether all marijuana should move to Schedule III. The outcome of that hearing could fundamentally change the regulatory landscape for the adult-use operations that currently sit outside the reclassification.

What operators should do right now

For California licensees who have not yet submitted their DEA registration applications, the message is urgent and clear.

Submit before June 22. The benefits of the priority window — priority review, safe harbor, and target six-month turnaround — are too significant to forfeit. Every day of delay reduces the time available to address any issues that arise during the application process.

Consult compliance counsel. DEA registration involves compliance requirements that most cannabis operators have not previously encountered. Record-keeping standards, security requirements, and reporting obligations under the Controlled Substances Act differ from state cannabis compliance frameworks. Legal counsel with DEA registration experience can identify gaps between current operations and federal requirements before they become problems.

Prepare for dual-track compliance. Operators with both medical and adult-use licenses need to establish systems for maintaining separate compliance records for each program. The operational requirements for DEA-registered medical activities and state-licensed adult-use activities will differ, and operators need accounting, inventory, and record-keeping systems that can handle both.

Monitor the June 29 hearing. The broader rescheduling hearing beginning one week after the registration window closes could change the landscape for adult-use operations. Operators should track the hearing's progress and be prepared to respond to whatever framework emerges for non-medical cannabis.

The significance of the moment

California's cannabis industry is experiencing the most rapid regulatory transformation in its history. In the span of weeks, state-licensed medical marijuana has moved from Schedule I to Schedule III, the DEA has opened registration to cannabis operators for the first time, the DCC has issued emergency regulations to facilitate the transition, and the broader rescheduling hearing that could extend these changes to the entire cannabis market is about to begin.

For the approximately 1,600 California licensees pursuing DEA registration, the June 22 deadline is the most immediate priority. The safe harbor protection alone justifies the effort — without it, the legal status of medical cannabis operations during the registration process remains ambiguous in ways that create risk for operators, employees, and patients.

Three weeks remain. The window does not extend.